partnering

Strategy

Inositec has an extensive drug discovery platform based on analogs of inositol. Inositec will pursue development of its lead compounds to treat vascular and renal calcification disorders through clinical proof-of-concept. The company is seeking to partner certain drug candidate and discovery assets, particularly in the Clostridium difficile infection program.

For further information on business development opportunities, contact  info@inositec.com